Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
Autor: | Capehorn, M.S., Catarig, A.-M., Furberg, J.K., Janez, A., Price, H.C., Tadayon, S., Vergès, B., Marre, M. |
---|---|
Zdroj: | In Diabetes & Metabolism April 2020 46(2):100-109 |
Databáze: | ScienceDirect |
Externí odkaz: |